Designing mitophagy-targeted robustine- and 4-acridinol-rhodium( <scp>iii</scp> ) coordination compounds to overcome cisplatin resistance in A549/DDP lung cancer cells
This study aimed to develop a potential theranostic metal-containing drug for overcoming cisplatin (cisPt)-based resistance in A549/DDP lung cancer cells.
Authors
- Chun-Jie Liang
- Ming‐Xiong Tan
- Qi‐Pin Qin (ORCID: https://orcid.org/0000-0001-9596-4512)
- Hong Liao (ORCID: https://orcid.org/0000-0002-6702-7289)
- Tingting Shao (ORCID: https://orcid.org/0000-0003-0069-1510)
- Qiuming Li (ORCID: https://orcid.org/0009-0008-2045-3054)
- Hong Liang (ORCID: https://orcid.org/0000-0002-1979-2509)
Institutions
- Guizhou University (CN)
- Yulin Normal University (CN)
- Guangxi Normal University (CN)
Publication Details
- Journal
- New Journal of Chemistry
- Published
- 2025-12-05
- DOI
- https://doi.org/10.1039/d5nj02700d
- Primary Topic
- Metal complexes synthesis and properties
- Type
- article
- Field-Weighted Citation Impact
- 0.00